When was EquiSeq founded?

EquiSeq was founded in 2015 and raised its 1st funding round within a year of its incorporation.

Where is EquiSeq located?

EquiSeq is headquartered in Albuquerque, United States.

How many employees does EquiSeq have?

As of Aug 31, 2026, the latest employee count at EquiSeq is 2.

Is EquiSeq a funded company?

EquiSeq is a funded company, having raised a total of $974K across 4 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Sep 18, 2015.

When was the latest funding round of EquiSeq?

EquiSeq's latest funding was a $***** Seed round on Sep 24, 2019, with participation from 0 investor. Its primary sector is Genomics. In United States, the Genomics sector has seen $2.25B in funding in 2026 to date.

Where does EquiSeq rank among its competitors?

EquiSeq ranks 41st amongst 124 active competitors, of which 15 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was FERAGEN, which secured an undisclosed amount in Aug, 2026.

Who are the top competitors of EquiSeq?

EquiSeq's top competitors include Embark Veterinary, Hendrix Genetics and Basepaws. Among them, FERAGEN secured the most recent funding round in August, 2026.

EquiSeq - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of genetic tests for horses. It provides DNA tests for better breeding of horses and to breed out undesirable traits. It offers genetic tests for conditions common in some breeds, like Polysaccharide Storage Myopathy type 2 (PSSM2), Recurrent Exertional Rhabdomyolysis (RER), and Myofibrillar Myopathy (MFM). It has also developed tests for three genetic variants that predispose a horse to Polysaccharide Storage Myopathy type 2 (PSSM2) or Myofibrillar Myopathy (MFM), a subtype of PSSM2.

Website: equiseq.com
Social
Email ID: *****@equiseq.com

Key Metrics

Founded Year

2015

Location

Albuquerque, United States

Stage

Seed

Total Funding

$974K in 4 rounds

Latest Funding Round

Seed, Sep 24, 2019, $*****

Investors

pitchfiesta.com

Ranked

41^st among 124 active competitors

Employee Count

2 as on Aug 31, 2026

Similar Companies

Embark Veterinary & 127 more

View EquiSeq's full profile

EquiSeq is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
EquiSeq Inc CIN: 474925037 , United States, Active	Dec 31, 2014	-	-	-

EquiSeq has raised a total funding of $974K over 4 rounds. Its first funding round was on Sep 18, 2015. EquiSeq has 1 institutional investor.

Here is the list of recent funding rounds of EquiSeq:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 24, 2019	1452170	Seed	1999686	6115590	2917017	7816677
May 17, 2017	7120948	Seed	3997589	7692488	2613178	9830080
Dec 30, 2015	5026252	Seed	6455047	7408493	4967782	7977308

Access funding benchmarks and valuations. Sign up today!

View details of EquiSeq's funding rounds and investors

EquiSeq's employee count trend

EquiSeq has 2 employees as of Aug 26. Here is EquiSeq's employee count trend over the years:

Uncover EquiSeq's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of EquiSeq include Embark Veterinary, Hendrix Genetics and Basepaws. Here is the list of Top 10 competitors of EquiSeq, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Embark Veterinary 2015, Austin (United States), Series B	Proivder of DNA test kits for dogs that enable dog owners to provide better pet care	$94.3M	SoftBank Vision Fund, F-Prime Capital & 19 others	74/100
2nd	Hendrix Genetics 2005, Boxmeer (Netherlands), Acquired	Provider of breeding programs for multiple animal species and related technologies	-	Gates, Rabo Investments & 5 others	58/100
3rd	Basepaws 2016, Mountain View (United States), Acquired	Provider of genetic testing for cats	$250K	GingerBread Capital, Broocknell Ventures ... & 17 others	50/100
4th	AnimalBiome 2016, San Francisco (United States), Series B	Provider of animal microbiome based diagnostics services for pet care	$25.9M	Cargill, TiE & 9 others	48/100
5th	Proteon Pharmaceuticals 2005, Lodz (Poland), Series B	Developer of bacteriophage-based products for livestock farming and aquaculture health	$28.8M	Nutreco, Aqua Spark & 7 others	43/100
6th	Bactana Corporation 2016, Farmington (United States), Acquired	Developer of proprietary microbiome technology	$1.76M	Cornell, Connecticut Innovations & 7 others	42/100
7th	BioPet Laboratories 2008, Knoxville (United States), Unfunded	Provider of DNA proof test for parentage of canines	-	-	42/100
8th	MiDOG 2018, Irvine (United States), Unfunded	Provider of DNA Sequencing for identification of pathogens and antibiotic resistances in dogs	-	-	41/100
9th	FERAGEN 2012, Salzburg (Austria), Seed	Provider of DNA test kits for the evaluation of dog health	-	Raiffeisen Bank	41/100
10th	Salmobreed 2001, Bergen (Norway), Acqui-Hired	Provider of genetic selection and biosecurity technologies for aquaculture industries	-	-	39/100
41st	EquiSeq 2015, Albuquerque (United States), Seed	Provider of genetic tests for horses	$974K	pitchfiesta.com	26/100